英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
75428查看　75428　在百度字典中的解释百度英翻中〔查看〕
75428查看　75428　在Google字典中的解释Google英翻中〔查看〕
75428查看　75428　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Non-Small Cell Lung Cancer Treatment - NCI
    Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy Laser therapy, photodynamic therapy, cryosurgery, and electrocautery may be used Learn more about NSCLC in this expert-reviewed summary
  • Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI
    Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy Get detailed information about newly diagnosed and recurrent NSCLC in this summary for clinicians
  • Non-small Cell Lung Cancer Treatment by Stage
    Learn about treatment options for non-small cell lung cancer (NSCLC), including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy
  • Metastatic Non-Small Cell Lung Cancer - NCCN
    What is metastatic NSCLC? Metastatic non-small cell lung cancer (NSCLC) is an abnormal spreading of certain types of lung cancer cells into the lining of the lung or to another organ This description is important because treatment differs between lung cancer types and where lung cancer is in the body
  • Metastatic Non-Small Cell Lung Cancer: Symptoms, Treatment, and More
    When non-small cell lung cancer spreads to other areas of the body, it is metastatic cancer Learn more about treatment, symptoms, and outlook for people living with metastatic NSCLC
  • Metastatic Lung Cancer | Signs, Prognosis, Treatment
    Immunotherapy is a common metastatic non-small cell lung cancer treatment, according to Yale Medicine Lung cancer immunotherapy boosts the immune system to recognize and attack cancer cells
  • Non–Small Cell Lung Cancer Metastatic Without Oncogenic Alterations
    This overview provides a thorough review of current treatment approaches for first-line management of nononcogenic addicted non–small cell lung cancer We also address pertinent clinical decision-making queries encountered in everyday practice, such as the optimal treatment strategy for PD-L1
  • Recent advances in therapeutic strategies for non-small cell lung . . .
    The development of targeted therapy with small-molecule tyrosine kinase inhibitors and immunotherapy with immune checkpoints inhibitors has ushered in the era of precision medicine in treating lung cancer, which remains the leading cause of cancer-related deaths worldwide Both targeted therapy and immunotherapy have significantly improved the survival of patients with metastatic non-small
  • Non–Small Cell Lung Cancer, Version 4. 2026, NCCN Clinical Practice . . .
    The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance, and subsequent treatment The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data This selection from
  • Survival outcomes of patients with metastatic non-small cell lung . . .
    Abstract Treatment of metastatic non-small cell lung cancer (mNSCLC) has been modified due to the development of immunotherapy





中文字典-英文字典  2005-2009